US Patent Issued to Bristol-Myers Squibb on May 20 for "Pyrazolo[3,4-dpyrrolo[1,2-bpyridazinyl compounds useful as IRAK4 inhibitors" (Pennsylvania Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,304,914, issued on May 20, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Pyrazolo[3,4-dpyrrolo[1,2-bpyridazinyl compounds useful as IRAK4 inhibitors" was invented by Hong Wu (New Hope, Pa.) and John Hynes (Washington Crossing, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compounds of Formula (I) or a salt or prodrug thereof, wherein R1, R2, R3, R4, and are defined herein. Also disclosed are methods of using such compounds as modulators of IRAK4, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing inflammatory and autoimmune diseases, or in the treatm...